ENALAPRILAT - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for enalaprilat and what is the scope of freedom to operate?

Enalaprilat is the generic ingredient in two branded drugs marketed by Chartwell Injectable, Dr Reddys, Hikma Farmaceutica, Hospira, and Biovail Labs Intl, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for enalaprilat. Three suppliers are listed for this compound.

Summary for ENALAPRILAT

US Patents:	0
Tradenames:	2
Applicants:	5
NDAs:	7
Drug Master File Entries:	8
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	73
Clinical Trials:	11
Patent Applications:	5,046
What excipients (inactive ingredients) are in ENALAPRILAT?	ENALAPRILAT excipients list
DailyMed Link:	ENALAPRILAT at DailyMed

Recent Clinical Trials for ENALAPRILAT

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Maryland, Baltimore	Phase 4
University of Guadalajara	Phase 2
Ethicare GmbH	Phase 2/Phase 3

See all ENALAPRILAT clinical trials

Pharmacology for ENALAPRILAT

Drug Class	Angiotensin Converting Enzyme Inhibitor
Mechanism of Action	Angiotensin-converting Enzyme Inhibitors
Physiological Effect	Decreased Blood Pressure

Medical Subject Heading (MeSH) Categories for ENALAPRILAT

Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents

US Patents and Regulatory Information for ENALAPRILAT

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	ENALAPRILAT	enalaprilat	INJECTABLE;INJECTION	075456-001	Aug 22, 2000		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hospira	ENALAPRILAT	enalaprilat	INJECTABLE;INJECTION	075571-001	Aug 22, 2000		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Dr Reddys	ENALAPRILAT	enalaprilat	INJECTABLE;INJECTION	075578-001	Aug 22, 2000	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ENALAPRILAT

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Biovail Labs Intl	VASOTEC	enalaprilat	INJECTABLE;INJECTION	019309-001	Feb 9, 1988	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.